Please assess the completion status of the following clinical trial:

Trial Title: Ertapenem for Initial Empirical Treatment of Third Generation Cephalosporin Resistant Enterobacteriaceae Bacteremia

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adults, either sex, ages 18 years or above~* Patients with 3GCRE bacteremia~* Patients admitted to any of the study sites~Exclusion Criteria:~* Discontinuation of antibiotic due to transition to hospice care~* Polymicrobial bacteremia~* Empirical antibiotic after 24 hours of first evidence of bacteremia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Ertapenem (Type: None): Patients who received ertapenem as an empirical antibiotic
- Other carbapenems (Type: None): Patients who received carbapenems other than ertapenem as an empirical antibiotic

Based on this trial design, predict the completion outcome and termination type (if applicable).